Salix Pharma, Norgine Announce FDA Approval Of PLENVU - Quick Facts

Shutterstock photo

(RTTNews.com) - Salix Pharmaceuticals, Ltd. a subsidiary of Valeant Pharmaceuticals International, Inc. ( VRX ), and its partner Norgine announced the U.S. FDA has approved PLENVU, a lower-volume polyethylene glycol based bowel preparation. PLENVU is also the only FDA-approved bowel cleanser to offer split dosing on the same day as the colonoscopy procedure.

PLENVU was licensed by Salix from Norgine in August 2016 for introduction to the U.S. market and will be available in the U.S market in the third quarter of 2018. In Europe, PLENVU is approved and available through Norgine.

Read the original article on RTTNews (http://www.rttnews.com/2891534/salix-pharma-norgine-announce-fda-approval-of-plenvu-quick-facts.aspx)

For comments and feedback: contact editorial@rttnews.com

This article appears in: World Markets , Stocks
Referenced Symbols: VRX

More from RTT News


See All RTT news

Research Brokers before you trade

Want to trade FX?